Skip to content

Clinical trials

Phase 2 Esophageal Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 2 Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20111
20162
20171
20181
20191
20203
20211
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed5
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center2
Jazz Pharmaceuticals2
AstraZeneca1
Bayer1
BeiGene1
Daiichi Sankyo1
Elevation Oncology1
Hallym University Medical Center1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms17
Stomach Neoplasms8
Cholangiocarcinoma5
Ovarian Neoplasms5
Pancreatic Neoplasms5
Breast Neoplasms4
Colorectal Neoplasms4
Endometrial Neoplasms4
Gallbladder Neoplasms4
Urinary Bladder Neoplasms4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.